Jeffrey D. Meng

FDA investigator

Appears on 14 documents from 2010 to 2016, mostly at sites in Michigan. Most often cites production record review (21 CFR 211.192).

14
Documents on file
7.8
Observations per 483
2010
First seen
2016
Most recent

What they cite most

From 83 observations

Activity by year

2010: 1, 2013: 3, 2014: 3, 2015: 6, 2016: 1

Where

Michigan 11 · China 2 · Texas 1

Is Jeffrey D. Meng coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

14 documents, newest first
FirmOpen
483 University Of MichiganJun 29, 2016 · Ann Arbor, Michigan
483 Downing Labs, LLCOct 9, 2015 · Dallas, Texas
483 Pharmacia & Upjohn Company LLCJul 9, 2015 · Kalamazoo, Michigan
Response Health Dimensions, Inc.May 21, 2015 · Farmington Hills, Michigan
483 Tri-Med, Inc. dba Advanced Care Infusion-ShelbyFeb 23, 2015 · Shelby Township, Michigan
483 Chongqing Daxin Pharmaceutical Co. Ltd.Jan 29, 2015 · Shuitu Town, Beibei District, China
483 Hangzhou Huadong Medicine Group Kangrun PharmaceuticalJan 22, 2015 · Xiaofeng Town, Anji, China

About this profile

What does Jeffrey D. Meng inspect?

Jeffrey D. Meng appears on 14 documents on file covering 10 sites, mostly in Michigan.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.42 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jeffrey D. Meng is dated Jun 29, 2016.